Evidence map›Paper›PMID 30982858›Full record

SynthesisThe American journal of clinical nutrition2019

Associations of circulating very-long-chain saturated fatty acids and incident type 2 diabetes: a pooled analysis of prospective cohort studies.

Amanda M Fretts, Fumiaki Imamura, Matti Marklund, Renata Micha, Jason H Y Wu, Rachel A Murphy, Kuo-Liong Chien, Barbara McKnight, Nathan Tintle, Nita G Forouhi and 31 more

Open access · bronzeAbstract readMeta-Analysis
In one paragraph

Synthesis in The American journal of clinical nutrition, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 5 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 5 syntheses or guidelines pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Article
  9. [The Relationship Between Serum Very Long-chain Saturated Fatty Acids and Chronic Kidney Disease].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

41 authors at 20 institutions in 11 countries.

Amanda M FrettsDepartment of Epidemiology.
Fumiaki ImamuraMRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Matti MarklundClinical Nutrition and Metabolism, Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.
Renata MichaFriedman School of Nutrition Science and Policy, Tufts University, Boston, MA.
Jason H Y WuThe George Institute for Global Health, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.
Rachel A MurphySchool of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
Kuo-Liong ChienInstitute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
Barbara McKnightCardiovascular Health Research Unit.
Nathan TintleDepartment of Statistics.
Nita G ForouhiMRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Waqas T QureshiDivision of Cardiovascular Medicine.
Jyrki K VirtanenInstitute of Public Health and Clinical Nutrition.
Kerry WongCancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
Alexis C WoodUSDA / Agricultural Research Service Children's Nutrition Research Center, Baylor College of Medicine, Houston, TX.
Maria LankinenInstitute of Public Health and Clinical Nutrition.
Kalina RajaobelinaUniversity of Bordeaux, Inserm, Bordeaux Population Health Research Center, Bordeaux, France.
Tamara B HarrisNational Institute on Aging, NIH, Bethesda, MD.
Luc DjousséDivisions of Aging, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Bill HarrisOmegaQuant Analytics, Sioux Falls, SD.
Nick J WarehamMRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Lyn M SteffenDivision of Epidemiology and Community Health, School of Public Health.
Markku LaaksoInstitute of Clinical Medicine, Internal Medicine, University of Eastern Finland, Kuopio, Finland.
Jenna VeenstraDepartment of Biology, Dordt College, Sioux Center, IA.
Cécilia SamieriUniversity of Bordeaux, Inserm, Bordeaux Population Health Research Center, Bordeaux, France.
Ingeborg A BrouwerDepartment of Health Sciences, Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Chaoyu Ian YuDepartment of Biostatistics.
Albert KoulmanMRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Brian T SteffenLaboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN.
Catherine HelmerUniversity of Bordeaux, Inserm, Bordeaux Population Health Research Center, Bordeaux, France.
Nona SotoodehniaCardiovascular Health Research Unit.
David SiscovickNew York Academy of Medicine, New York, NY.
Vilmundur GudnasonIcelandic Heart Association, Kópavogur, Iceland.
InterAct Consortium
Lynne WagenknechtDivision of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC.
Sari VoutilainenInstitute of Public Health and Clinical Nutrition.
Michael Y TsaiLaboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN.
Matti UusitupaInstitute of Public Health and Clinical Nutrition.
Anya KalsbeekDepartment of Biology, Dordt College, Sioux Center, IA.
Claudine BerrInserm, University of Montpellier, Neuropsychiatry: Epidemiological and Clinical Research, Montpellier, France.
Dariush MozaffarianFriedman School of Nutrition Science and Policy, Tufts University, Boston, MA.
Rozenn N LemaitreCardiovascular Health Research Unit.
Institute of Public Health · ALUniversité de Bordeaux · FRUniversity of Cambridge · GBDordt University · USTufts University · USUniversity of Minnesota · USUniversity of Washington · USUppsala University · SEAgricultural Research Service · USBrigham and Women's Hospital · USCancer Council Victoria · AUFaculty of Public Health · GBInserm · FRMRC Human Nutrition Research · GBNational Institute on Aging · USNational Taiwan University · TWNew York Academy of Medicine · USUniversity of British Columbia · CAUniversity of Eastern Finland · FIUniversity of Iceland · IS

Funding

Institute for Clinical and Translational ResearchUL1TR001079 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2013 to 2017
$60.1M
Wake Forest Clinical and Translational Science AwardUL1TR001420 · NCATS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ARD, JAMY D, FOLEY, KRISTIE L · 2015 to 2023
$32.3M
Clinical and Translational Science AwardUL1TR000040 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2012 to 2015
$26.2M
NCCIH Supplement to NCATS/CTSA Program for KL2 Scholars - M. SoddersKL2TR002317 · NCATS · UNIVERSITY OF WASHINGTON · PI Christy Michelle McKinney · 2017 to 2026
$14.5M
Institute of Translational Health SciencesKL2TR000421 · NCATS · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2012 to 2016
$12.6M
QUANTITATION OF FACTORS REGULATING GLUCOSE TOLERANCER01DK029867 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MARILYN ADER · 1986 to 2026
$11.0M
Exceptional Survival: Trajectories to Functional Aging (CHS All Stars)R01AG023629 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI NEWMAN, ANNE B. · 2004 to 2016
$9.5M
New York Regional Center for Diabetes Translation Research - Translational Intervention Methodology CoreP30DK111022 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI JEFFREY GONZALEZ · 2016 to 2026
$7.8M
CHS research resources for the cardiovascular health of older adultsU01HL130114 · NHLBI · UNIVERSITY OF WASHINGTON · PI BURKE, GREGORY L, KRONMAL, RICHARD A · 2016 to 2019
$6.6M
CHS Events Follow-up StudyU01HL080295 · NHLBI · UNIVERSITY OF WASHINGTON · PI PSATY, BRUCE M · 2005 to 2008
$4.6M
Insulin Clearance: Candidate and Positional Genetic DeterminantsR01DK079888 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI GOODARZI, MARK · 2008 to 2012
$1.7M
INSULIN RESISTANCE AND ATHEROSCLEROSIS STUDY (IRAS)U01HL047902 · NHLBI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI SAAD, MOHAMMED F · 1991 to 1999
–
Medical Research Council G0800783Medical Research Council MC_UD99999906Medical Research Council MC_UU_12015/1Medical Research Council MC_UU_12015/5NCATS NIH HHS KL2 TR000421NCATS NIH HHS KL2 TR002317NCATS NIH HHS UL1 TR000040NCATS NIH HHS UL1 TR001079NCATS NIH HHS UL1 TR001420NHLBI NIH HHS HHSN268200800007CNHLBI NIH HHS HHSN268201200036CNHLBI NIH HHS HHSN268201600001CNHLBI NIH HHS HHSN268201600002CNHLBI NIH HHS HHSN268201600003CNHLBI NIH HHS HHSN268201600004CNHLBI NIH HHS HHSN268201600018CNHLBI NIH HHS HHSN268201800001CNHLBI NIH HHS U01 HL047892NHLBI NIH HHS U01 HL047902NHLBI NIH HHS U01 HL080295NHLBI NIH HHS U01 HL130114NIA NIH HHS N01 AG012100NIA NIH HHS R01 AG023629NIDDK NIH HHS P30 DK111022NIDDK NIH HHS R01 DK029867NIDDK NIH HHS R01 DK079888NIH HHS HHSN263201500003I
6 · The paper itself

Abstract

backgroundSaturated fatty acids (SFAs) of different chain lengths have unique metabolic and biological effects, and a small number of recent studies suggest that higher circulating concentrations of the very-long-chain SFAs (VLSFAs) arachidic acid (20:0), behenic acid (22:0), and lignoceric acid (24:0) are associated with a lower risk of diabetes. Confirmation of these findings in a large and diverse population is needed.

objectiveWe investigated the associations of circulating VLSFAs 20:0, 22:0, and 24:0 with incident type 2 diabetes in prospective studies.

methodsTwelve studies that are part of the Fatty Acids and Outcomes Research Consortium participated in the analysis. Using Cox or logistic regression within studies and an inverse-variance-weighted meta-analysis across studies, we examined the associations of VLSFAs 20:0, 22:0, and 24:0 with incident diabetes among 51,431 participants.

resultsThere were 14,276 cases of incident diabetes across participating studies. Higher circulating concentrations of 20:0, 22:0, and 24:0 were each associated with a lower risk of incident diabetes. Pooling across cohorts, the RR (95% CI) for incident diabetes comparing the 90th percentile to the 10th percentile was 0.78 (0.70, 0.87) for 20:0, 0.84 (0.77, 0.91) for 22:0, and 0.75 (0.69, 0.83) for 24:0 after adjustment for demographic, lifestyle, adiposity, and other health factors. Results were fully attenuated in exploratory models that adjusted for circulating 16:0 and triglycerides.

conclusionsResults from this pooled analysis indicate that higher concentrations of circulating VLSFAs 20:0, 22:0, and 24:0 are each associated with a lower risk of diabetes.

Indexed as

AdultAgedAged, 80 and overDiabetes Mellitus, Type 2Eicosanoic AcidsFatty AcidsFemaleHumansMaleMiddle AgedProspective Studiesarachidic acidbehenic acidEicosanoic AcidsFatty Acidslignoceric acidCohorts for Heart and Aging Research in Genomic EpidemiologydiabetesFatty Acids and Outcomes Research Consortiummeta-analysissaturated fatty acidsvery-long-chain saturated fatty acids

Identifiers

PMID30982858
PMCPMC6500926
OpenAlexW2936962484

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.